Helicobacter pylori seropositivity in patients with unstable angina

Journal of Cardiovascular Surgery

Volumn 44, Issue 5, 2003, Pages 605-609

  Pellicano, R ^a   Mazzarello, M G ^b   Morelloni, S ^b   Ferrari, M ^b   Angelino, P ^c   Berrutti, M ^a   Torriglia, A M ^b   Rizzetto, M ^a,d   Ponzetto, A ^a,d  

^a MOLINETTE HOSPITAL   (Italy)

^b ASL 22   (Italy)

^c Rivoli Hospital   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Angina, unstable; Helicobacter plylori; Myorcardial infarction; Myorcardial ischemia

Indexed keywords

BACTERIUM ANTIBODY; CHOLESTEROL; CREATINE KINASE MB; FIBRINOGEN; GLUCOSE; IMMUNOGLOBULIN G; TROPONIN T;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ITALY; MALE; MEDICAL ASSESSMENT; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SMOKING HABIT; SOCIAL CLASS; SOCIAL STATUS; UNSTABLE ANGINA PECTORIS; WORKPLACE;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0942266220     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
2. Shaper AG, Pocock SJ, Walker M, Phillips AN, Whitehead TP, MacFarlane PW. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health 1985;39:197-209.
3. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
4. Gueli N, Del Nero A, Zia N, Carmenini E, Carmenini G. Life habits and cardiovascular risk in a group of bank employees in Rome. Panminerva Med 2001;41:187-92.
5. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-26.
6. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
7. Stone AFM, Mendall MA. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case favour. Dig Liver Dis 2000;32:62-4.
8. Cammarota G, Pasceri V, Gasbarrini A, Gasbarrini G. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. Dig Liver Dis 2000;32:65-8.
9. Pellicano R, Rizzetto M, Ponzetto A. Helicobacter pylori infection and coronary heart disease. A continuously debated question. Panminerva Med 2001;43:139-40.
10. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999;319:1157-62.
11. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JWG, Sweetnam PM et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation 1998;98: 1286-90.
12. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA 2002 Guideline. Update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of patients with unstable angina). ACC 2002; http://www.acc.org/clinicalguidelines/unstable/unstable.pdf.
13. Pellicano R, Parravicini PP, Bigi R, Gandolfo N, Aruta E, Gai V et al. Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? Microbiologica 2002;25:315-21.
14. Spinzi G, Pellicano R, Minoli G, Terreni N, Cutufia MA, Fagoonee S et al. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med 2001;43:85-7.
15. Danielli E. A fuorometric enzyme-linked immunosorbent assay for serological diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1993;5 Suppl 2:S57-9
16. Suriani R, Venturini I, Colozza M, Bona F, Cardesi E, Mazzucco D. Helicobacter pylori antibodies (CagA and VacA) detection. The link between cancer and infection. Minerva Gastroenterol Dietol 2002;48:159-64.
17. Pellicano R, Rizzetto M. Extragastric manifestations of Helicobacter species infections. Do these bacteria act as triggers? Minerva Gastroenterol Dietol 2002;48:179-87.
18. Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001;33:222-9.
19. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000;38:4408-11.
20. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
21. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Gentiloni Silveri N, Gasbarrini G et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens. Possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002;106:430-4.
22. Figura N, Palazzuoli A, Faglia S, Lenzi C, Borrello F, Palazzuoli V et al. Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease. Prevalence and association with exercise-induced electrocardiographic abnormalities. Dig Dis Sci 2002;47:831-6.
23. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005.
24. Aguejouf O, Mayo K, Malfatti E, Doutremepuich C, Mégraud F. Arterial thrombosis and chronic Helicobacter pylori infection in mice [abstract]. Gut 1998;43 Suppl 2:A104.
25. Laurila A, Bloigu A, Nayha S, Hassi L, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999;142:207-10.
26. Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified profile. Arterioscler Thromb Vasc Biol 2001;21:427-32.
27. Parente F, Imbesi V, Cucino C, Maconi G, Russo U, Duca PG et al. Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. J Intern Med 2000;247:213-7.
28. Torgano G, Cosentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999;99:1555-9.
29. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2.
30. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998;97:1675-9.
31. De Luis DA, San Roman AL, Lahera M, Aller R, Canton R, De la Calle H et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998;21:1129-32
32. Kahan T, Lundman P, Olsson G, Wendt M. Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis 2000;11:523-6.
33. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
34. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivor of myocardial infarction. Circulation 1997;96:404-7.
35. Stone AFM, Mendall MA, Kaski J, Edger TM, Gupta S, Poloniecki J et al. The South Thames trial of antibiotics in myocardial infarction and unstable angina [abstract]. Eur Heart J 2001;22:643.
36. Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Role of known risk factors in explaining the difference in the risk of coronary heart disease between Eastern and Southwestern Finland. Ann Med 1998;30:481-7.
37. Braunwald E. Shattuck letture. Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities. N Engl J Med 1997;337:1360-9.
38. Cremonini F, Canducci F, Gabrielli M, Di Caro S, Santarelli L, Nista EC et al. Helicobacter pylori: a culprit in extraintestinal diseases? Minerva Gastroenterol Dietol 2001;47:129-35.